143 related articles for article (PubMed ID: 15317721)
1. Partial resolution of diabetic macular oedema after systemic treatment with furosemide.
Ciardella AP
Br J Ophthalmol; 2004 Sep; 88(9):1224-5. PubMed ID: 15317721
[No Abstract] [Full Text] [Related]
2. Resolution of macular edema after systemic treatment with furosemide.
Koo NK; Kim YC
Korean J Ophthalmol; 2012 Aug; 26(4):312-5. PubMed ID: 22870034
[TBL] [Abstract][Full Text] [Related]
3. Severe macular edema induced by pioglitazone in a patient with diabetic retinopathy: a case study.
Oshitari T; Asaumi N; Watanabe M; Kumagai K; Mitamura Y
Vasc Health Risk Manag; 2008; 4(5):1137-40. PubMed ID: 19183764
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and diabetic macular oedema in type 2 diabetes mellitus.
Zapata MA; Badal J; Fonollosa A; Boixadera A; García-Arumí J
Br J Ophthalmol; 2010 Sep; 94(9):1230-2. PubMed ID: 20542983
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravitreal bevacizumab on macular and peripapillary choroidal thickness in injected and fellow eyes of patients with diabetic macular oedema.
Örnek N; Örnek K; Oğurel T; Timur İE
Acta Ophthalmol; 2015 Dec; 93(8):e684-6. PubMed ID: 25683321
[No Abstract] [Full Text] [Related]
6. Vascular endothelial growth factor gene polymorphism prevalence in patients with diabetic macular oedema and its correlation with anti-vascular endothelial growth factor treatment outcomes.
El-Shazly SF; El-Bradey MH; Tameesh MK
Clin Exp Ophthalmol; 2014; 42(4):369-78. PubMed ID: 23927080
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide for the treatment of diffuse diabetic macular oedema--a case report.
Wang C; Katz BJ; Turner MJ; Hu J; Zhang K
Ann Acad Med Singap; 2006 Feb; 35(2):112-4. PubMed ID: 16565766
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography.
Kumar A; Sinha S
Ophthalmology; 2008 Feb; 115(2):417-8; author reply 418. PubMed ID: 18243920
[No Abstract] [Full Text] [Related]
9. Gender-related differences in patients treated with intravitreal anti-vascular endothelial growth factor medication for diabetic macular oedema.
Schiefelbein J; Müller M; Kern C; Herold T; Liegl R; Fasler K; Jeliazkova D; Priglinger S; Kortuem KU
Eur J Ophthalmol; 2020 Nov; 30(6):1410-1417. PubMed ID: 31937122
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing clinical outcomes in patients with diabetic macular edema treated with intravitreal ranibizumab: comparison between responder and non-responder cases.
Chen YP; Wu AL; Chuang CC; Chen SN
Sci Rep; 2019 Jul; 9(1):10952. PubMed ID: 31358777
[TBL] [Abstract][Full Text] [Related]
11. Diabetic macular edema.
Narula R; Agarwal M; Chaudhary SP; Shroff C
Ophthalmology; 2009 Sep; 116(9):1833-4; author reply 1834. PubMed ID: 19729104
[No Abstract] [Full Text] [Related]
12. Outcome and Predictors for 2-Year Visual Acuity in Eyes with Diabetic Macular Edema Treated with Ranibizumab.
Eski Yucel O; Birinci H; Sullu Y
J Ocul Pharmacol Ther; 2019 May; 35(4):229-234. PubMed ID: 30896316
[No Abstract] [Full Text] [Related]
13. Quantification of fluid resorption from diabetic macular oedema with foveal serous detachment after dexamethasone intravitreal implant (Ozurdex
Hodzic-Hadzibegovic D; Ba-Ali S; Valerius M; Lund-Andersen H
Acta Ophthalmol; 2017 May; 95(3):324-325. PubMed ID: 27778454
[TBL] [Abstract][Full Text] [Related]
14. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
Kernt M; Cserhati S; Seidensticker F; Liegl R; Kampik A; Neubauer A; Ulbig MW; Reznicek L
Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
[TBL] [Abstract][Full Text] [Related]
15. Three-month outcomes of ziv-aflibercept in the treatment of diabetic macular oedema.
Ashraf M; Souka AA; El Kayal H; El Manhaly M; Abdallah MH
Acta Ophthalmol; 2016 Nov; 94(7):e669. PubMed ID: 27227354
[No Abstract] [Full Text] [Related]
16. Diabetic macular edema.
Jonas J; Rensch F
Ophthalmology; 2009 Mar; 116(3):594-5; author reply 596-7. PubMed ID: 19264219
[No Abstract] [Full Text] [Related]
17. Diabetic macular edema.
Gillies M
Ophthalmology; 2009 Mar; 116(3):595; author reply 596-7. PubMed ID: 19264220
[No Abstract] [Full Text] [Related]
18. Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes.
Kumar A; Alfahad Q; Mitra A; Elsherbiny S; Lip PL
Eye (Lond); 2016 May; 30(5):763-4. PubMed ID: 26795414
[No Abstract] [Full Text] [Related]
19. Qualitative and Quantitative Assessment of Vascular Changes in Diabetic Macular Edema after Dexamethasone Implant Using Optical Coherence Tomography Angiography.
Toto L; D'Aloisio R; Di Nicola M; Di Martino G; Di Staso S; Ciancaglini M; Tognetto D; Mastropasqua L
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574436
[TBL] [Abstract][Full Text] [Related]
20. Diabetic macular edema.
Kim SJ
Ophthalmology; 2009 Jun; 116(6):1228.e1; author reply 1228-9. PubMed ID: 19486803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
